Company intelligence / Profile preview

Mizar Therapeutics

Woods Hole, Massachusetts, United Statesmizartx.com ↗

Ownership: Private
Development stage: Other

Overview

Mizar Therapeutics has developed a proprietary live-cell super-resolution imaging and AI-based analysis platform to identify new cancer treatment compounds by tracking real-time activity of target proteins in living cells. The company’s approach enables unprecedented insight into protein behavior for SAR-enabled drug discovery, target validation, and mechanism-of-action studies. No clinical results have been reported as of June 2025.

Therapeutic areas: Oncology
Modalities: Small moleculePotentially others
Industry: Drug Discovery Services

Partnerships

No major pharmaceutical or biotech partnerships have been publicly announced as of June 2025.

Beyond the preview

Go deeper on Mizar Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mizar Therapeutics.

Explore the full profile